批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/09/19 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/09/19 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/09/19 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/09/19 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/08/10 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/08/10 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/06/26 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/06/26 |
SUPPL-9(补充) |
Approval |
Labeling |
|
|
|
2009/04/06 |
SUPPL-7(补充) |
Approval |
Labeling |
|
|
|
2009/01/22 |
SUPPL-6(补充) |
Approval |
Labeling |
|
|
|
2008/08/13 |
SUPPL-4(补充) |
Approval |
Labeling |
|
|
|
2007/10/19 |
SUPPL-3(补充) |
Approval |
Labeling |
|
|
|
2005/04/27 |
SUPPL-1(补充) |
Approval |
Labeling |
|
|
|
2004/10/28 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:CITALOPRAM HYDROBROMIDE 剂型/给药途径:TABLET;ORAL 规格:EQ 10MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020822 |
001 |
NDA |
CELEXA |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
Yes |
No |
AB |
2000/04/27
|
ABBVIE |
077031 |
001 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2004/10/28
|
AUROBINDO |
077038 |
001 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2004/10/28
|
DR REDDYS LABS LTD |
077042 |
001 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2004/11/05
|
MYLAN |
077044 |
001 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2004/11/05
|
CHARTWELL MOLECULAR |
077048 |
001 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 10MG BASE |
Discontinued |
No |
No |
AB |
2004/11/16
|
COSETTE |
077046 |
001 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2004/11/24
|
APOTEX |
077045 |
003 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2005/04/29
|
EPIC PHARMA |
077534 |
001 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2006/10/03
|
INVAGEN PHARMS |
077289 |
001 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2006/11/30
|
AMNEAL PHARMS NY |
078216 |
001 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2007/03/27
|
TORRENT PHARMS |
077654 |
001 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 10MG BASE |
Prescription |
No |
No |
AB |
2009/02/27
|
GLENMARK PHARMS LTD |
活性成分:CITALOPRAM HYDROBROMIDE 剂型/给药途径:TABLET;ORAL 规格:EQ 20MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020822 |
002 |
NDA |
CELEXA |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
Yes |
No |
AB |
1998/07/17
|
ABBVIE |
077031 |
002 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2004/10/28
|
AUROBINDO |
077038 |
002 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2004/10/28
|
DR REDDYS LABS LTD |
077042 |
002 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2004/11/05
|
MYLAN |
077044 |
002 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2004/11/05
|
CHARTWELL MOLECULAR |
077048 |
002 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 20MG BASE |
Discontinued |
No |
No |
AB |
2004/11/16
|
COSETTE |
077046 |
002 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2004/11/24
|
APOTEX |
077045 |
002 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2005/04/29
|
EPIC PHARMA |
077534 |
002 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2006/10/03
|
INVAGEN PHARMS |
077289 |
002 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2006/11/30
|
AMNEAL PHARMS NY |
078216 |
002 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2007/03/27
|
TORRENT PHARMS |
077654 |
002 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 20MG BASE |
Prescription |
No |
No |
AB |
2009/02/27
|
GLENMARK PHARMS LTD |
活性成分:CITALOPRAM HYDROBROMIDE 剂型/给药途径:TABLET;ORAL 规格:EQ 40MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020822 |
003 |
NDA |
CELEXA |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 40MG BASE |
Prescription |
Yes |
Yes |
AB |
1998/07/17
|
ABBVIE |
077031 |
003 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 40MG BASE |
Prescription |
No |
No |
AB |
2004/10/28
|
AUROBINDO |
077038 |
003 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 40MG BASE |
Prescription |
No |
No |
AB |
2004/10/28
|
DR REDDYS LABS LTD |
077042 |
003 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 40MG BASE |
Prescription |
No |
No |
AB |
2004/11/05
|
MYLAN |
077044 |
003 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 40MG BASE |
Prescription |
No |
No |
AB |
2004/11/05
|
CHARTWELL MOLECULAR |
077048 |
003 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 40MG BASE |
Discontinued |
No |
No |
AB |
2004/11/16
|
COSETTE |
077046 |
003 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 40MG BASE |
Prescription |
No |
No |
AB |
2004/11/24
|
APOTEX |
077045 |
001 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 40MG BASE |
Prescription |
No |
No |
AB |
2005/04/29
|
EPIC PHARMA |
077534 |
003 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 40MG BASE |
Prescription |
No |
No |
AB |
2006/10/03
|
INVAGEN PHARMS |
077289 |
003 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 40MG BASE |
Prescription |
No |
No |
AB |
2006/11/30
|
AMNEAL PHARMS NY |
078216 |
003 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 40MG BASE |
Prescription |
No |
No |
AB |
2007/03/27
|
TORRENT PHARMS |
077654 |
003 |
ANDA |
CITALOPRAM HYDROBROMIDE |
CITALOPRAM HYDROBROMIDE |
TABLET;ORAL |
EQ 40MG BASE |
Prescription |
No |
No |
AB |
2009/02/27
|
GLENMARK PHARMS LTD |